The Endocrine Society has hired Michel Y. Farhat, PhD — a seasoned executive with more than 20 years of experience in the pharmaceutical industry — to serve as its chief strategic partnerships officer.
In his new role, Farhat will develop and execute a global strategic partnerships strategy. He will identify opportunities to collaborate with stakeholders to provide information and tools for Society members and endocrine patients worldwide. He also will lead the Society’s Corporate Liaison Board, which forges partnerships between the Society and senior executives in industry.
Farhat brings extensive experience building strategic alliances and networks of influencers and organizations to this position. He spent the past five years serving as senior director, Patient and Professional Advocacy, for Novo Nordisk Inc. Prior to leading Novo Nordisk’s professional advocacy function, he spent 15 years in various medical affairs and professional advocacy roles for Procter and Gamble’s over-the-counter brands and pharmaceutical products.
“The Endocrine Society is forming important collaborations that expand access to care, accelerate discovery, and promote public health,” Farhat says. “I am honored to have the opportunity to foster these important connections and build new relationships that will be instrumental in our leadership of the global endocrine community.”
Farhat has served on boards and committees for the American Academy of Family Physicians, JDRF, the American Heart Association, and other medical industry professional organizations.
“Michel’s extensive experience building partnerships and deep understanding of the healthcare industry are valued assets for our team,” says Society CEO Barbara Byrd Keenan, FASAE, CAE. “True collaborations are essential for achieving our ambitious goals of unifying and growing the endocrine field. We are delighted to welcome Michel to our team.”
Farhat understands Society members’ careers as a veteran of academic research. He spent 10 years at Georgetown University Medical Center, where he ultimately became an associate professor. Farhat graduated with his Doctor of Philosophy degree in pharmacology from the American University of Beirut. He is fluent in English, Arabic, and French.